Echocardiographic and Hemodynamic Predictors of Survival in Precapillary Pulmonary Hypertension: Seven-Year Follow-Up

Background—In this study, we looked at the prognostic value of echocardiographic and hemodynamic measures in a large cohort of patients with precapillary pulmonary hypertension before and after initiation of treatment. Methods and Results—Data were collected prospectively in a cohort of consecutive patients with precapillary pulmonary hypertension referred between 2002 and 2011. A range of clinical and echocardiographic variables were collected and stored on a database to assess predictors of survival. Invasive hemodynamic data including pulmonary artery pressure, pulmonary vascular resistance, capillary wedge pressure, and cardiac index were also obtained at baseline in all patients. Outcome was defined as mortality because of cardiovascular-related death. The study cohort comprised 777 patients (514 women) with precapillary pulmonary hypertension. A total of 195 (25%) died. In multivariable analysis, moderate or severe tricuspid regurgitation (hazard ratio [HR], 26.537; 95% confidence interval, 11.536–61.044; P<0.001), right ventricular myocardial performance index (HR, 3.421; 95% confidence interval, 1.777–6.584; P<0.001), and the presence of pericardial effusion (HR, 1.38; 95% confidence interval, 1.023–1.862; P=0.035) were independent predictors of mortality. High pulmonary vascular resistance and right atrial pressure by invasive hemodynamic measurements were independent predictors of mortality (HR, 1.084; 95% confidence interval, 1.041–1.130, and 1.079, respectively; 95% confidence interval, 1.049–1.111; P<0.001 for both), whereas patients with a higher cardiac index had better survival overall (HR, 0.384; 95% confidence interval, 0.307–0.481; P<0.001). Conclusions—Right ventricular dysfunction, moderate–severe tricuspid regurgitation, low cardiac index, and raised right atrial pressure were associated with poor survival for both pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertensive disease patients. The severity of tricuspid regurgitation, myocardial performance index, presence of pericardial effusion, pulmonary vascular resistance, cardiac index, and right atrial pressure may be used to stratify risk of death.

[1]  P. Hassoun,et al.  Comprehensive invasive and noninvasive approach to the right ventricle-pulmonary circulation unit: state of the art and clinical and research implications. , 2009, Circulation.

[2]  Gilles Garcia,et al.  Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. , 2002, Journal of the American College of Cardiology.

[3]  N. Reichek.  Right ventricular strain in pulmonary hypertension: flavor du jour or enduring prognostic index? , 2013, Circulation. Cardiovascular imaging.

[4]  Christopher S Coffey,et al.  Predicting Survival in Pulmonary Arterial Hypertension: Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) , 2010, Circulation.

[5]  R. Levine,et al.  American Society of Echocardiography: recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography , 2003 .

[6]  A. Torbicki,et al.  The role of echocardiography in the diagnosis and management of patients with pulmonary hypertension , 2010, European Respiratory Review.

[7]  M. Humbert,et al.  The study of risk in pulmonary arterial hypertension , 2012, European Respiratory Review.

[8]  G. Koch,et al.  Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. , 2002, Journal of the American College of Cardiology.

[9]  L. Gambotti,et al.  Usefulness of right ventricular isovolumic relaxation time in predicting systolic pulmonary artery pressure. , 2008, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[10]  S. Fuchs,et al.  Gender‐related differences in hospitalized heart failure patients , 2013, European journal of heart failure.

[11]  T. Lumley,et al.  Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker , 2000, Biometrics.

[12]  Nico Westerhof,et al.  Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy. , 2011, Journal of the American College of Cardiology.

[13]  R. Levine,et al.  Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. , 2003, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[14]  J. Lordan,et al.  Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland. , 2012, American journal of respiratory and critical care medicine.

[15]  S. Ghio,et al.  Prognostic relevance of the echocardiographic assessment of right ventricular function in patients with idiopathic pulmonary arterial hypertension. , 2010, International journal of cardiology.

[16]  G. Simonneau,et al.  Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial , 2008, The Lancet.

[17]  W P Santamore,et al.  Ventricular interdependence: significant left ventricular contributions to right ventricular systolic function. , 1998, Progress in cardiovascular diseases.

[18]  T. Athanasiou,et al.  Morphologic and functional remodeling of the right ventricle in pulmonary hypertension by real time three dimensional echocardiography. , 2012, The American journal of cardiology.

[19]  J. Feinstein,et al.  Extension of Doppler-derived echocardiographic measures of pulmonary vascular resistance to patients with moderate or severe pulmonary vascular disease. , 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[20]  A. Shillington,et al.  Survival in Primary Pulmonary Hypertension: The Impact of Epoprostenol Therapy , 2002, Circulation.

[21]  M. Humbert,et al.  Survival and prognostic factors in systemic sclerosis-associated pulmonary hypertension: a systematic review and meta-analysis. , 2013, Arthritis and rheumatism.

[22]  S. Archer,et al.  PGC1α-mediated mitofusin-2 deficiency in female rats and humans with pulmonary arterial hypertension. , 2013, American journal of respiratory and critical care medicine.

[23]  W. Mckenna,et al.  Echocardiographic measurement of the normal adult right ventricle , 1986 .

[24]  Jeffrey C. Hill,et al.  Assessment of the right ventricle by echocardiography: a primer for cardiac sonographers. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[25]  H. Dittrich,et al.  Pericardial Adaptation in Severe Chronic Pulmonary Hypertension: An Intraoperative Transesophageal Echocardiographic Study , 1992, Circulation.

[26]  Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era , 2010, Circulation.

[27]  J. Zamorano,et al.  European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). , 2010, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[28]  Jayant Nath,et al.  Impact of tricuspid regurgitation on long-term survival. , 2004, Journal of the American College of Cardiology.

[29]  F. Sheehan,et al.  The right ventricle: anatomy, physiology and clinical imaging , 2008, Heart.

[30]  N. Westerhof,et al.  The arterial load in pulmonary hypertension , 2010, European Respiratory Review.

[31]  S. Solomon,et al.  GUIDELINES AND STANDARDS , 2010 .

[32]  Arthur E. Weyman,et al.  Clinical Correlates and Reference Intervals for Pulmonary Artery Systolic Pressure Among Echocardiographically Normal Subjects , 2001, Circulation.

[33]  L. Badano,et al.  Right ventricle in pulmonary arterial hypertension: haemodynamics, structural changes, imaging, and proposal of a study protocol aimed to assess remodelling and treatment effects. , 2010, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[34]  Yuhui Zhang,et al.  Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in "out-of-proportion" pulmonary hypertension. , 2013, Chest.

[35]  H. Calkins,et al.  Comparison of novel echocardiographic parameters of right ventricular function with ejection fraction by cardiac magnetic resonance. , 2007, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[36]  J B Seward,et al.  Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension. , 1998, The American journal of cardiology.

[37]  P. Pellikka,et al.  Outcome Prediction by Quantitative Right Ventricular Function Assessment in 575 Subjects Evaluated for Pulmonary Hypertension , 2013, Circulation. Cardiovascular imaging.

[38]  Luke S. Howard,et al.  Echocardiographic assessment of pulmonary hypertension: standard operating procedure , 2012, European Respiratory Review.

[39]  J. Newman,et al.  High Prevalence of Occult Pulmonary Venous Hypertension Revealed by Fluid Challenge in Pulmonary Hypertension , 2014, Circulation. Heart failure.

[40]  Horst Olschewski,et al.  Updated clinical classification of pulmonary hypertension. , 2009, Journal of the American College of Cardiology.

[41]  L. Tavazzi,et al.  Acute heart failure patient profiles, management and in‐hospital outcome: results of the Italian Registry on Heart Failure Outcome , 2012, European journal of heart failure.

[42]  E H Bergofsky,et al.  Survival in Patients with Primary Pulmonary Hypertension: Results from a National Prospective Registry , 1991 .

[43]  A. Sheel,et al.  Clinical review: Guyton - the role of mean circulatory filling pressure and right atrial pressure in controlling cardiac output , 2010, Critical care.

[44]  R. Benza,et al.  Management of pulmonary arterial hypertension with a focus on combination therapies. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[45]  T. Abraham,et al.  Tricuspid annular displacement predicts survival in pulmonary hypertension. , 2006, American journal of respiratory and critical care medicine.

[46]  Richard D. White,et al.  ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. , 2010, Circulation.

[47]  K. Cleary,et al.  Pulmonary arterial hypertension in pregnancy. , 2014, Seminars in perinatology.